Biomolecules & Biomedicine (Apr 2021)
2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina
- Semir Bešlija,
- Zdenka Gojković,
- Timur Cerić,
- Alma Mekić Abazović,
- Inga Marijanović,
- Semir Vranić,
- Jasminka Mustedanagić–Mujanović,
- Faruk Skenderi,
- Ivanka Rakita,
- Aleksandar Guzijan,
- Dijana Koprić,
- Alen Humačkić,
- Danijela Trokić,
- Jasmina Alidžanović,
- Alma Efendić,
- Ibrahim Šišić,
- Harun Drljević,
- Vanesa Bešlagić,
- Božana Babić,
- Azra Pašić,
- Anela Ramić,
- Dijana Mikić,
- Zlatko Guzin,
- Dragana Karan,
- Teo Buhovac,
- Dragana Miletić,
- Senad Šečić,
- Azra Đozić Šahmić,
- Lejla Mujbegović,
- Alisa Kubura,
- Mensura Burina,
- Nenad Lalović,
- Nikolina Dukić,
- Jelena Vladičić Mašić,
- Mirjana Ćuk,
- Rajna Stanušić
Affiliations
- Semir Bešlija
- ORCiD
- Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina
- Zdenka Gojković
- University Clinical Center of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina
- Timur Cerić
- ORCiD
- Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina
- Alma Mekić Abazović
- Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina
- Inga Marijanović
- University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
- Semir Vranić
- ORCiD
- Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina; Current affiliation: College of Medicine, QU Health, Qatar University, Doha, Qatar
- Jasminka Mustedanagić–Mujanović
- University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina
- Faruk Skenderi
- ORCiD
- Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina
- Ivanka Rakita
- University Clinical Center of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina
- Aleksandar Guzijan
- University Clinical Center of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina
- Dijana Koprić
- University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina
- Alen Humačkić
- Cantonal Hospital “Dr Safet Mujić”, Mostar, Bosnia and Herzegovina
- Danijela Trokić
- Radiotherapy Center, International Medical Centers, Banja Luka, Bosnia and Herzegovina
- Jasmina Alidžanović
- University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina
- Alma Efendić
- Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina
- Ibrahim Šišić
- Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina
- Harun Drljević
- Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina
- Vanesa Bešlagić
- Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina
- Božana Babić
- University Clinical Center of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina
- Azra Pašić
- Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina
- Anela Ramić
- Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina
- Dijana Mikić
- University Clinical Center of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina
- Zlatko Guzin
- Cantonal Hospital “Dr Safet Mujić”, Mostar, Bosnia and Herzegovina
- Dragana Karan
- University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
- Teo Buhovac
- University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
- Dragana Miletić
- University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
- Senad Šečić
- Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina
- Azra Đozić Šahmić
- Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina
- Lejla Mujbegović
- Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina
- Alisa Kubura
- Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina
- Mensura Burina
- University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina
- Nenad Lalović
- University Hospital Foča, Foča, Bosnia and Herzegovina
- Nikolina Dukić
- University Hospital Foča, Foča, Bosnia and Herzegovina
- Jelena Vladičić Mašić
- University Hospital Foča, Foča, Bosnia and Herzegovina
- Mirjana Ćuk
- University Hospital Foča, Foča, Bosnia and Herzegovina
- Rajna Stanušić
- University Hospital Foča, Foča, Bosnia and Herzegovina
- DOI
- https://doi.org/10.17305/bjbms.2020.4846
- Journal volume & issue
-
Vol. 21,
no. 2
Abstract
The HERe2Cure project, which involved a group of breast cancer experts, members of multidisciplinary tumor boards from healthcare institutions in Bosnia and Herzegovina, was initiated with the aim of defining an optimal approach to the diagnosis and treatment of HER2 positive breast cancer. After individual multidisciplinary consensus meetings were held in all oncology centers in Bosnia and Herzegovina, a final consensus meeting was held in order to reconcile the final conclusions discussed in individual meetings. Guidelines were adopted by consensus, based on the presentations and suggestions of experts, which were first discussed in a panel discussion and then agreed electronically between all the authors mentioned. The conclusions of the panel discussion represent the consensus of experts in the field of breast cancer diagnosis and treatment in Bosnia and Herzegovina. The objectives of the guidelines include the standardization, harmonization and optimization of the procedures for the diagnosis, treatment and monitoring of patients with HER2-positive breast cancer, all of which should lead to an improvement in the quality of health care of mentioned patients. The initial treatment plan for patients with HER2-positive breast cancer must be made by a multidisciplinary tumor board comprised of at least: a medical oncologist, a pathologist, a radiologist, a surgeon, and a radiation oncologist/radiotherapist.
Keywords
